Pharmion

Pharmion is a global specialty pharmaceutical company that is dedicated to the hematology and oncology communities. With proven development and regulatory professionals and an experienced global commercialization team, we concentrate our resources on acquiring, developing, and commercializing innovative products.



We work in partnership with a network of scientific and clinical advisors to identify and develop these products for global markets. To expand each product's potential, we have established our own commercial organizations in the United States, Europe, and Australia and have created distribution partnerships in 30 additional countries. With this international network we can reach physicians and their patients in more than 40 countries.



Through these efforts, we seek to provide greater therapeutic options to hematologists and oncologists with the ultimate goal of extending survival and improving patients' quality of life.

Contact Details: 2525 28th St., Suite 200 Boulder CO 80301 United States of America Tel: +1 720 564 9100 Fax: +1 720 564 9191 Email: IR@Pharmion.com WWW: www.pharmion.com/

Loading...

Recent Publications by Pharmion:
Epigenetic alterations and cancer: new targets for therapy. Over the last two decades, preclinical and clinical research has...	6th December, 2007	Pharmion Corp, 1700 Owens Street, Suite 205, San Francisco, CA 94158, USA.	IDrugs. 2007 Oct;10(10):709-12.
Future directions in haematology: beyond multiple myeloma. Thalidomide acts on the microenvironment of myelodysplastic syndromes...	14th October, 2005	Pharmion	Acta Haematol. 2005;114 Suppl 1:27-32. DOI Direct Link

BioNews Results for Pharmion:
Disparities in the Use of Chemotherapy and Monoclonal Antibody Therapy for Elderly Advanced Colorectal Cancer	The Oncologist:  Aug 29 2008 12:49AM Matching: pharmion
Celgene Wins US Approval to Expand Vidaza Label	Therapeutics Daily:  Aug 21 2008 1:49PM Matching: pharmion
Sucampo Pharmaceuticals Announces Key Management and Board Appointments at its European Affiliate	DiGiTAL50:  Aug 13 2008 11:59AM Matching: pharmion
Celgene Withdraws European Marketing Application for Orplatna	FDA News:  Aug 12 2008 10:12PM Matching: pharmion
Sucampo Pharmaceuticals Announces Key Management and Board Appointments at its European Affiliate	Healthcare Sales & Marketing Network:  Aug 9 2008 4:43PM Matching: pharmion
Promote your company here: BioNewsCast - Press Release Distribution	→View more Pharmion news.

Pharmion Patents:
US Patent No.	Title
7192781	Methods for stabilizing 5-azacytidine in plasma
7078518	Forms of 5-Azacytidine
7038038	Synthesis of 5-azacytidine
6943249	Methods for isolating crystalline Form I of 5-azacytidine
6887855	Forms of 5-azacytidine
→View more Pharmion patents.

Pharmion (PHRM) Financial information Links from Barchart
PHRM Quote from from Barchart.com
PHRM Chart from from Barchart.com
PHRM Profile from from Barchart.com
PHRM Opinion from from Barchart.com
→View more Pharmion finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 157 times since April 2007, the link to the organisation's website has been followed 25 times

Recent Search Terms used to find this page: pharmion.com | PHARMION SAN FRANCISCO | pharmion corp | pharmion.com | pharmion uk tel | IDrugs. 2007 Oct 10 10 709-12 | IDrugs. 2007 Oct 10 10 709-12 | .

Search for more companies in Boulder

Search for more companies in CO

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Pharmion